Related Experiment Video
Updated: Nov 8, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery
Lei Jiang1, Sensen Zhou1, Xiaoke Zhang1
1MOE Key Laboratory of High Performance Polymer Materials and Technology, and Department of Polymer Science and Engineering, College of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
Researchers developed a new liposomal delivery platform for cancer therapy. This platform targets mitochondria, enhancing drug delivery and leading to complete tumor eradication in mice.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Mitochondria are crucial for cellular energy and are sensitive targets for cancer treatments like photothermal and photodynamic therapy.
- Targeting therapeutics to mitochondria is challenging due to their intracellular location and the complex cellular environment.
- Current mitochondrion-targeting systems, such as those based on triphenylphosphonium (TPP), have limitations in delivery efficacy.
Purpose of the Study:
- To develop a novel mitochondrion-targeted liposomal delivery platform for enhanced cancer treatment.
- To design a system with pH-sensitive and charge-reversible properties for improved tumor accumulation and cell penetration.
- To compare the efficacy of the new platform against existing TPP-based systems.
Main Methods:
- A guanidinium-based dendritic peptide moiety was incorporated into liposomes to mimic mitochondrial transmembrane signaling.
- The resulting dendritic lipopeptide (DLP) liposomal platform was designed to be pH-sensitive and charge-reversible.
- The DLP platform's mitochondrion-targeting efficacy was evaluated and compared to TPP-based systems.
- The efficacy of combined photothermal and photodynamic therapies delivered by the DLP platform was assessed in mice with 4T1 mammary tumors.
Main Results:
- The novel DLP liposomal delivery platform demonstrated enhanced mitochondrion-targeted delivery.
- The DLP platform showed approximately 3.7-fold higher mitochondrion-targeting efficacy compared to TPP-based systems.
- Complete eradication of 4T1 mammary tumors was achieved in mice treated with combined photothermal and photodynamic therapies delivered by the DLP platform.
Conclusions:
- The developed DLP liposomal platform effectively targets mitochondria for cancer therapy.
- This platform offers improved delivery efficacy and enhanced therapeutic outcomes compared to existing systems.
- The DLP platform holds significant promise for advancing combined photothermal and photodynamic cancer treatments.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondrial Membranes

